Crossmark

Green-Synthesized Silver Nanoparticles Coated with Alginate and Conjugated to Docetaxel Drug: Combination Therapy Under X-Irradiation on LNCaP Prostate Cancer Cells

Crossref DOI link: https://doi.org/10.1007/s10924-025-03591-8

Published Online: 2025-05-15

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Keshavarz, Benyamin

Gharbavi, Mahmoud

Bagherpour, Ghasem

Rezaeejam, Hamed

Johari, Behrooz
Funding

Funding for this research was provided by:

Zanjan University of Medical Sciences (A-12-1244-27 & Ethical Code: IR.ZUMS.BLC.1402.028)
License Information

Text and Data Mining valid from 2025-05-15

Version of Record valid from 2025-05-15
More Information

Article History

Accepted: 3 May 2025

First Online: 15 May 2025

Declarations

:

: The authors declare no competing interests.

: Not applicable. LNCaP (C439) was purchased from the Pasteur Institute of Iran (Tehran, Iran).

: Not applicable.

Document is current

Any future updates will be listed below